ORAGENICS INC — Director's Dealing 2017

Feb 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN.BC)
CIK: 0001174940
Period of Report: 2017-02-09

Reporting Person: KOSKI FAMILY LP (10% Owner)
Reporting Person: KOSKI ROBERT C (Director, 10% Owner)
Reporting Person: KOSKI THOMAS L (10% Owner)
Reporting Person: KOSKI CHRISTINE L (10% Owner)
Reporting Person: KOSKI BEVERLY (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-09	Common Stock	A	40000	$0.00	Acquired	1047878	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12864822	Direct
Common Stock	1572523	Direct
Common Stock	919666	Direct
Common Stock	28000	Indirect
Common Stock	530851	Indirect

Footnotes

F1: Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.

F2: Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F3: Shares owned directly by Christine L. Koski.

F4: Shares owned directly by Robert C. Koski, a director of the Company.

F5: Shares owned directly by Thomas L. Koski.

F6: Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).

F7: Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.

F8: Represents an award of restricted stock in connection with service to the Company as director pursuant to the 2012 Equity Incentive Plan that vest equally over each of the four calendar quarters during 2017.